Asia Pacific Anesthesia Drugs Market

Asia Pacific Anesthesia Drugs Market by Drug Types (General Anesthesia Drugs [Propofol, Sevoflurane, Isoflurane, Dexmedetomidine, Remifentanil, Desflurane, Midazolam, and Others], Local Anesthesia Drugs [Lidocaine, Ropivacaine, Chloroprocaine, Articaine, Benzocaine, Bupivacaine, and Others ]), Route of Administrations (Injection, Inhalation, and Others), Applications (General Surgery, Plastic Surgery, Cosmetic Surgeries, Dental Surgeries, and Others), and Geography (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific) - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028.

  • Report ID: HC-3674
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 212
  • Format:
  • Pub. Date: Upcoming
  • Share:

The Asia Pacific anesthesia drugs market size is anticipated to expand at a significant CAGR during the forecast period, 2021–2028. The growth of the market is attributed to increasing awareness about the safe surgical procedures.


Asia Pacific Anesthesia Drugs Market summary

An anesthetic is a painkiller used during surgery. Many pieces of equipment, such as anesthetic vaporizers and nasal oxygen sets are specifically built for certain surgical procedures. Almost all surgical procedures today require anesthesia. Anesthesia functions by preventing nerve signals from reaching the brain and keeping the patient awake. Procedures can be performed without the patient experiencing anything during this stage of induced sleep. Nerve signals are able to reach the brain once the anesthesia wears off.

Market Trends, Drivers, Restraints, and Opportunities

  • Increasing prevalence of chronic diseases and surgical procedure such as bypass surgery and pain control is anticipated to drive market growth.
  • Decreasing efficacy of current drugs can hamper the market expansion.
  • Favorable reimbursement policies can positively influence the market growth in the projected timeline.
  • Expanding investment in R&D for developing novel and efficient drugs are creating ample opportunities for the anesthesia drugs market.

Scope of the Report

The report on the Asia Pacific anesthesia drugs market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Anesthesia Drugs Market - Asia-Pacific Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Drug Types (General Anesthesia Drugs[Propofol, Sevoflurane, Isoflurane, Dexmedetomidine, Remifentanil, Desflurane, Midazolam, and Others], Local Anesthesia Drugs [Lidocaine, Ropivacaine, Chloroprocaine, Articaine, Benzocaine , Bupivacaine, and Others]), Route of Administrations (Injection, Inhalation, and Others), Applications (General Surgery, Plastic Surgery, Cosmetic Surgeries, Dental Surgeries, and Others)

Geographical scope

China, Japan, India, Australia, South Korea, and Rest of Asia Pacific

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Aspen Holdings; Baxter International; AbbVie Inc; Fresenius SE & Co. KGaA; and B. Braun Melsungen AG

Asia-Pacific Anesthesia Drugs Market Segment Insights

Local anesthesia drugs segment is expected to grow at a rapid pace

Based on drugs types, the market is divided into general anesthesia drugs, and local anesthesia drugs. The general anesthesia drugs segment is classified as propofol, sevoflurane, isoflurane, dexmedetomidine, remifentanil, desflurane, midazolam, and others. The local anesthesia drugs segment is further categorized as lidocaine, ropivacaine, chloroprocaine, articaine, benzocaine, bupivacaine, and others. The local anesthesia drugs segment is expected to grow at a rapid pace during the forecast period owing to increasing number of accidents and surgeries.

Injection segment is projected to expand at a considerable CAGR

On the basis of route of administrations, the market is segregated into injection, inhalation, and others. The injection segment is projected to expand at a considerable CAGR during the forecast period due to technological advancements in drug delivery devices. Rising number of surgeries is propelling the segment growth.

Cosmetic surgeries segment is anticipated to account for a significant market share.

Based on applications, the market is divided into general surgery, plastic surgery, cosmetic surgeries, dental surgeries, and others. The cosmetic surgeries segment is estimated to account for a significant market share during the forecast period owing to rapid development of patient monitoring equipment and specially targeted medications.


Asia Pacific Anesthesia Drugs Market applications

Japan is anticipated to constitute a key market share

In terms of geography, the Asia Pacific anesthesia drugs market is categorized China, Japan, India, Australia, South Korea, and Rest of Asia Pacific. Japan is expected to constitute a key share of the market during the projected period due to early technological adoption and highly specialized healthcare infrastructure. On the other hand, the market in India is expected to grow at a rapid pace during the forecast period.

Segments

Segments Covered in the Report
The Asia Pacific anesthesia drugs market has been segmented on the basis of
Drug Types

  • General Anesthesia Drugs
    • Propofol
    • Sevoflurane
    • Isoflurane
    • Dexmedetomidine
    • Remifentanil
    • Desflurane
    • Midazolam
    • Others 
  • Local Anesthesia Drugs
    • Lidocaine
    • Ropivacaine
    • Chloroprocaine
    • Articaine
    • Benzocaine
    • Bupivacaine
    • Others

Route of Administrations

  • Injection
  • Inhalation
  • Others

Applications

  • General Surgery
  • Plastic Surgery
  • Cosmetic Surgeries
  • Dental Surgeries
  • Others

Geography

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Key Players

  • Aspen Holdings
  • Baxter International
  • AbbVie Inc
  • Fresenius SE & Co. KGaA
  • B. Braun Melsungen AG

 

Competitive Landscape

Key players competing in the Asia Pacific anesthesia drugs market are Aspen Holdings; Baxter International; AbbVie Inc; Fresenius SE & Co. KGaA; and B. Braun Melsungen AG.

Asia Pacific Anesthesia Drugs Market keyplayers

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Anesthesia Drugs Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Anesthesia Drugs Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Anesthesia Drugs Market - Supply Chain
  4.5. Global Anesthesia Drugs Market Forecast
     4.5.1. Anesthesia Drugs Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Anesthesia Drugs Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Anesthesia Drugs Market Absolute $ Opportunity
5. Global Anesthesia Drugs Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Anesthesia Drugs Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Anesthesia Drugs Demand Share Forecast, 2019-2026
6. North America Anesthesia Drugs Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Anesthesia Drugs Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Anesthesia Drugs Demand Share Forecast, 2019-2026
7. Latin America Anesthesia Drugs Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Anesthesia Drugs Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Anesthesia Drugs Demand Share Forecast, 2019-2026
8. Europe Anesthesia Drugs Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Anesthesia Drugs Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Anesthesia Drugs Demand Share Forecast, 2019-2026
9. Asia Pacific Anesthesia Drugs Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Anesthesia Drugs Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Anesthesia Drugs Demand Share Forecast, 2019-2026
10. Middle East & Africa Anesthesia Drugs Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Anesthesia Drugs Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Anesthesia Drugs Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Anesthesia Drugs Market: Market Share Analysis
  11.2. Anesthesia Drugs Distributors and Customers
  11.3. Anesthesia Drugs Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Aspen Holdings
     11.4.2. Baxter International
     11.4.3. AbbVie Inc
     11.4.4. Fresenius SE & Co. KGaA
     11.4.5. B. Braun Melsungen AG

Segments Covered in the Report
The Asia Pacific anesthesia drugs market has been segmented on the basis of
Drug Types

  • General Anesthesia Drugs
    • Propofol
    • Sevoflurane
    • Isoflurane
    • Dexmedetomidine
    • Remifentanil
    • Desflurane
    • Midazolam
    • Others 
  • Local Anesthesia Drugs
    • Lidocaine
    • Ropivacaine
    • Chloroprocaine
    • Articaine
    • Benzocaine
    • Bupivacaine
    • Others

Route of Administrations

  • Injection
  • Inhalation
  • Others

Applications

  • General Surgery
  • Plastic Surgery
  • Cosmetic Surgeries
  • Dental Surgeries
  • Others

Geography

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Key Players

  • Aspen Holdings
  • Baxter International
  • AbbVie Inc
  • Fresenius SE & Co. KGaA
  • B. Braun Melsungen AG

 

Key players competing in the Asia Pacific anesthesia drugs market are Aspen Holdings; Baxter International; AbbVie Inc; Fresenius SE & Co. KGaA; and B. Braun Melsungen AG.

Asia Pacific Anesthesia Drugs Market keyplayers

Buy Report